Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 15618 [2015-06652]
Download as PDF
<![CDATA[
15618
Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices
Effectiveness against LaboratoryConfirmed Influenza-Associated
Hospitalizations, FOA IP15–002, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time And Date: 10:00 a.m.–4:00 p.m.,
April 15, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters For Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Economic Studies of Immunization
Policies and Practices’’, FOA IP15–001
and ‘‘US Platform to Measure Influenza
Vaccine Effectiveness against
Laboratory-confirmed Influenzaassociated Hospitalizations’’, FOA IP15–
002.
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–06651 Filed 3–23–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Detection and Characterization
of Emerging Vector-Borne Zoonotic
Pathogens in Indonesia, CK15–001;
Sentinel Enhanced Dengue Surveillance
VerDate Sep<11>2014
01:09 Mar 24, 2015
Jkt 235001
System (SEDSS) Sites to Evaluate the
Epidemiology and Prevention of Dengue
and other Acute Febrile Illnesses in
Puerto Rico, CK15–002, and Capacity
Building to Prevent, Detect, and
Respond to Emerging Infectious Disease
Threats and Strengthen Global Health
Security in Uganda, CK15–003, Funding
Opportunity Announcement (FOA),
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time And Date: 11:00 a.m.–3:00 p.m.,
April 21, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters For Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Detection and Characterization of
Emerging Vector-Borne Zoonotic
Pathogens in Indonesia’’, FOA CK15–
001 and ‘‘Sentinel Enhanced Dengue
Surveillance System (SEDSS) Sites to
Evaluate the Epidemiology and
Prevention of Dengue and other Acute
Febrile Illnesses in Puerto Rico’’, FOA
CK15–002, and ‘‘Capacity Building to
Prevent, Detect, and Respond to
Emerging Infectious Disease Threats and
Strengthen Global Health Security in
Uganda’’, FOA CK15–003.
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Proposed Project
[FR Doc. 2015–06652 Filed 3–23–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
[30Day–15–15GD]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Emergency Self Escape for Coal
Miners—New—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15618]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06652]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Detection and Characterization
of Emerging Vector-Borne Zoonotic Pathogens in Indonesia, CK15-001;
Sentinel Enhanced Dengue Surveillance System (SEDSS) Sites to Evaluate
the Epidemiology and Prevention of Dengue and other Acute Febrile
Illnesses in Puerto Rico, CK15-002, and Capacity Building to Prevent,
Detect, and Respond to Emerging Infectious Disease Threats and
Strengthen Global Health Security in Uganda, CK15-003, Funding
Opportunity Announcement (FOA), initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time And Date: 11:00 a.m.-3:00 p.m., April 21, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters For Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Detection and Characterization of Emerging Vector-Borne Zoonotic
Pathogens in Indonesia'', FOA CK15-001 and ``Sentinel Enhanced Dengue
Surveillance System (SEDSS) Sites to Evaluate the Epidemiology and
Prevention of Dengue and other Acute Febrile Illnesses in Puerto
Rico'', FOA CK15-002, and ``Capacity Building to Prevent, Detect, and
Respond to Emerging Infectious Disease Threats and Strengthen Global
Health Security in Uganda'', FOA CK15-003.
Contact Person For More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-06652 Filed 3-23-15; 8:45 am]
BILLING CODE 4163-18-P
